The ability of mutant bovine growth hormones (bGH) to serve as either agonist or antagonist has been demonstrated in transgenic mice. We have prepared two transgenic strains of FVB/N mice, one expressing wild-type bGH and a second with a glutamic acid mutation at serine 84 in helix 2. Comparison of their phenotypes to those of nontransgenic littermates indicates that wild-type bGH induces a previously described phenotype for hyper-somatotrophic mice. In contrast, the replacement of the side chain hydroxyl at serine 84 with acetic acid produced a phenotype that expressed bGH at appreciable concentrations, but failed to elicit the phenotype observed with either an agonist or an antagonist of bGH. These results indicate that serine 84 is crucial for the activity of bGH despite this site being distal to the receptor binding surfaces.
KimBG, BrooksCL. Isolation and characterization of phosphorylated bovine prolactin. Biochem J296: 41–47, 1993.
14.
BrooksCL, IsaacsLA, WicksJR. Preparation and purification of phosphorylated and nonphosphorylated bovine prolactins. Mol Cell Endocrinol99: 301–305, 1994.
15.
WicksJR, BrooksCL. Biological activity of phosphorylated and dephosphorylated bovine prolactin. Mol Cell Endocrinol112: 223–229, 1995.
16.
BrooksCL, SaiduddinS.Phosphorylation of bovine prolactin eliminates luteotropic activity in the rat. Life Sci63: 1281–1287, 1998.
17.
SchenckEJH, CanfieldJM, BrooksCL. Functional relationship of serine 90 phosphorylation and the surrounding putative salt bridge in bovine prolactin. Mol Cell Endocrinol204: 117–125, 2003.
18.
MaciejewskiPM, PetersonFC, AndersonPJ, BrooksCL. Mutation of serine 90 to glutamic acid mimics phosphorylation of bovine prolactin. J Biol Chem270: 27661–27665, 1995.
AramburoC, DonoghueD, MontielJL, BerghmanLR, ScanesCG. Phosphorylation of chicken growth hormone. Life Sci47: 945–952, 1990.
21.
LibertiJP, AntoniBA, ChlebowskJR. Naturally-occurring pituitary growth hormone is phosphorylated. Biochem Biophys Res Commun128: 713–714, 1985.
22.
LibertiJP, JoshiGS. Synthesis and secretion of phosphorylated growth hormone by rat pituitary glands in vitro. Biochem Biophys Res Commun137:806–812, 1986.
PalmiterRD, BrinsterRL, HammerRE, TrumbauerME, RosenfeldMG, BimbergNC, EvansRM. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature300: 611–615, 1982.
25.
BartkeA, NaarEM, JohnsonL, MayMR, CecimM, YunJS, WagnerTE. Effects of expression of human or bGH genes on sperm production and male reproductive performance in four lines of transgenic mice, J Reprod Fertil95:109–118, 1992.
26.
CecimM, FaddenC, KerrJ, StegerRW, BartkeA.Infertility in transgenic mice overexpressing the bGH gene: disruption of neuroendocrine control of prolactin secretion during pregnancy. Biol Reprod52: 1187–1192, 1995.
27.
DoiT, StrikerLJ, QuaifeC, ContiFG, PalmiterR, BehringerR, BrinsterR, StrikerGE. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol131: 398–403, 1988.
28.
MullerAF, KopchickJJ, FlyvbjergA, van der LelyAJ. Growth hormone receptor antagonists. J Clin Endocrinol Metab89: 1503–1511. 2004.
29.
ChenWY, WrightDC, MehtaBV, WagnerTE, KopchickJJ. Glycine 119 of bGH is critical for growth-promoting activity. Mol Endocrinol5: 1845–1852, 1991.
30.
PetersonFC, AndersonPJ, BerlinerLJ, BrooksCL. Expression, folding, and characterization of small proteins with increasing disulfide complexity by a PT7–7-derived phagemid. Protein Expr Purif15: 16–23, 1999.
